IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Serologic Characterization of Bone-healing
This study has been withdrawn prior to enrollment.
(Lack of patients, lack of funding for analysis)
Sponsor:
Northern Orthopaedic Division, Denmark
Collaborator:
CCBR Clinical Research Center, Aalborg, Denmark
Information provided by:
Northern Orthopaedic Division, Denmark
ClinicalTrials.gov Identifier:
NCT00377884
First received: September 18, 2006
Last updated: April 2, 2014
Last verified: April 2014
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Investigation of serologic bone markers in patients undergoing hip arthroplasty
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Serologic Based Molecular Characterization of Bone-healing After Cementless Total Hip Arthroplasty |
Further study details as provided by Northern Orthopaedic Division, Denmark:
| Enrollment: | 0 |
| Study Start Date: | January 2004 |
| Estimated Study Completion Date: | June 2009 |
| Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
Investigation of serologic bone markers in patients undergoing hip arthroplasty. Measured by frequent blood- and urine samples pre-operative and during the first post-operative year.
Eligibility| Ages Eligible for Study: | 40 Years to 80 Years (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
patients planned for cementless THR for OA in the hip
Criteria
Inclusion Criteria:
- Ages 40-80 years
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00377884
Please refer to this study by its ClinicalTrials.gov identifier: NCT00377884
Locations
| Denmark | |
| Northern Orthopaedic Division | |
| Aalborg, Northern Jutland, Denmark | |
| Aalborg University Hospital | |
| Aalborg, Denmark, 9000 | |
Sponsors and Collaborators
Northern Orthopaedic Division, Denmark
CCBR Clinical Research Center, Aalborg, Denmark
Investigators
| Principal Investigator: | Mogens B Laursen, MD, Phd | Northern Orthopaedic Division |
More Information
| Responsible Party: | Northern Orthopaedic Division, Orthopaedic Research Unit, Aarhus University - Aalborg Hospital, Denmark |
| ClinicalTrials.gov Identifier: | NCT00377884 History of Changes |
| Other Study ID Numbers: |
ON-04-018-MBL |
| Study First Received: | September 18, 2006 |
| Last Updated: | April 2, 2014 |
Keywords provided by Northern Orthopaedic Division, Denmark:
|
THA |
ClinicalTrials.gov processed this record on August 22, 2017